A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Posttraumatic Neuralgia..

PHASE2CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Nerve Pain
Interventions
DRUG

AZD2423

20 mg tablet

DRUG

AZD2423

50 mg tablet

DRUG

Placebo

Placebo

Trial Locations (25)

Unknown

Research Site, Pleven

Research Site, Sofia

Research Site, Aalborg

Research Site, Odense

Research Site, Boulogne-Billancourt

Research Site, Clermont-Ferrand

Research Site, Nice

Research Site, Saint-Priest-en-Jarez

Research Site, Gdansk

Research Site, Katowice

Research Site, Krakow

Research Site, Poznan

Research Site, Tychy

Research Site, Warsaw

Research Site, Kazan'

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Ufa

Research Site, Falköping

Research Site, Kristianstad

Research Site, Stockholm

Research Site, Birmingham

Research Site, Bradford

Research Site, Glasgow

Research Site, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY